≥98%, from Escherichia coli for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Colominic acid sodium salt from Escherichia coli is a chemical used to research on protein polysialylation processes. It is a substrate for CMP-NeuAc:(NeuAcα2→8)n (colominic acid) sialyltransferase.
| Pubchem Sid | 504771581 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504771581 |
| Canonical Smiles | CC(=O)NC1C(CC(OC1C(CO)O)O[CH]CO)O.[Na+].[Na+].[Na+] |
| InChIKey | IPYNPWIUCZLARC-XAIQJKFESA-N |
| INCHI | 1S/C11H20NO7.3Na/c1-6(15)12-10-7(16)4-9(18-3-2-13)19-11(10)8(17)5-14;;;/h3,7-11,13-14,16-17H,2,4-5H2,1H3,(H,12,15);;;/q;3*+1/t7-,8+,9?,10+,11+;;;/m0.../s1 |
| Isomeric SMILES | CC(=O)N[C@@H]1[C@H](CC(O[C@@H]1[C@@H](CO)O)O[CH]CO)O.[Na+].[Na+].[Na+] |
| WGK Germany | 3 |
| PubChem CID | 57369830 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 G2313225 | Certificate of Analysis | Apr 07, 2026 | C346576 |
| A2630365 | Certificate of Analysis | Jan 24, 2026 | C346576 |
| A2630366 | Certificate of Analysis | Jan 24, 2026 | C346576 |
| A2630364 | Certificate of Analysis | Jan 24, 2026 | C346576 |
| L2205138 | Certificate of Analysis | Sep 09, 2025 | C346576 |
| F2512379 | Certificate of Analysis | Jun 09, 2025 | C346576 |
| F2512378 | Certificate of Analysis | Jun 09, 2025 | C346576 |
| F2512342 | Certificate of Analysis | Jun 09, 2025 | C346576 |
| F2512341 | Certificate of Analysis | Jun 09, 2025 | C346576 |
| B2508193 | Certificate of Analysis | Dec 25, 2024 | C346576 |
| B2508211 | Certificate of Analysis | Dec 25, 2024 | C346576 |
| B2508205 | Certificate of Analysis | Dec 25, 2024 | C346576 |
| B2508213 | Certificate of Analysis | Dec 25, 2024 | C346576 |
| F2401119 | Certificate of Analysis | May 15, 2024 | C346576 |
| F2401113 | Certificate of Analysis | May 15, 2024 | C346576 |
| F2401111 | Certificate of Analysis | May 15, 2024 | C346576 |
| F2401110 | Certificate of Analysis | May 15, 2024 | C346576 |
| F2401106 | Certificate of Analysis | May 15, 2024 | C346576 |
| F2401105 | Certificate of Analysis | May 15, 2024 | C346576 |
| L2205110 | Certificate of Analysis | Nov 23, 2022 | C346576 |
| L2205112 | Certificate of Analysis | Nov 23, 2022 | C346576 |
| L2205134 | Certificate of Analysis | Nov 23, 2022 | C346576 |
| Solubility | Soluble in water (50 mg/ml). |
|---|---|
| Specific Rotation[α] | α20D+16±1, c = 1 in water |
| 1. Xu Lian, Chen Jiangwei, Zhang Wenli, Du Qianying, Huang Xin, Luo Ying, Wang Yi, Chen Sijin, Rong Xiyue, Liu Jia, Xu Zhongsheng, Ran Haitao, Liu Yun, Guo Dajing, Xu Jie. (2025) A bismuth-based nanoplatform with synergistic fibrin/NET disruption and antioxidant/anti-inflammatory capabilities for enhanced thrombolysis and prevention of deep vein thrombosis recurrence. JOURNAL OF NANOBIOTECHNOLOGY, [PMID:41299690] [10.1186/s12951-025-03864-3] |
